Related Experiment Video
Updated: Oct 5, 2025

Process Optimization using High Throughput Automated Micro-Bioreactors in Chinese Hamster Ovary Cell Cultivation
Published on: May 18, 2020
Maximizing data value for biopharma through FAIR and quality implementation: FAIR plus Q
Ian Harrow1, Rama Balakrishnan2, Hande Küçük McGinty3
1Pistoia Alliance, USA.
Abstract:
Over recent years, there has been exciting growth in collaboration between academia and industry in the life sciences to make data more Findable, Accessible, Interoperable and Reusable (FAIR) to achieve greater value. Despite considerable progress, the transformative shift from an application-centric to a data-centric perspective, enabled by FAIR implementation, remains very much a work in progress on the 'FAIR journey'. In this review, we consider use cases for FAIR implementation. These can be deployed alongside assessment of data quality to maximize the value of data generated from research, clinical trials, and real-world healthcare data, which are essential for the discovery and development of new medical treatments by biopharma.
More Related Videos
08:01Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
Published on: November 30, 2022
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
Related Concept Videos
Bioequivalence Data: Statistical Interpretation
Drug Products: Biologics, Biosimilars and Interchangeables
Biopharmaceutical Factors Influencing Drug Product Design: Overview
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
Bioavailability Study Design: Healthy Subjects Versus Patients
Bioequivalence studies: Biowaivers